T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery. (Q39501413)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Swan CH

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Bühler B

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Steinberger P

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Barbas CF 3rd

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Torbett BE

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1480-1492

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Genetic acceleration of AIDS progression by a promoter variant of CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Dendritic cell-mediated viral transfer to T cells is required for human immunodeficiency virus type 1 persistence in the face of rapid cell turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Intracellular antibodies (intrabodies) for gene therapy of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Expression of CD4 controls the susceptibility of THP-1 cells to infection by R5 and X4 HIV type 1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Development and applications of the SCID-hu mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

The SCID-hu mouse as a model for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Current status of gene therapy strategies to treat HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Gene therapy progress and prospects: novel gene therapy approaches for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Efficient marking of murine long-term repopulating stem cells targeting unseparated marrow cells at low lentiviral vector particle concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Co-receptor antagonists as HIV-1 entry inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

A review of vaccines for HIV prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

21 January 2018

Is resistance futile?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Virus entry as a target for anti-HIV intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Structure-function studies of the HIV-1 coreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Structural interactions between chemokine receptors, gp120 Env and CD4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Chemokine receptor CCR5: insights into structure, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

HIV preferentially infects HIV-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

CCR5 deficiency increases risk of symptomatic West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFP-modified CD34+ baboon repopulating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

Hierarchical binding of DNA fragments derived from scaffold-attached regions: correlation of properties in vitro and function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

7 January 2021

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

7 January 2021

Development of a self-inactivating lentivirus vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

7 January 2021

Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

7 January 2021

Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302801

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302801

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16738691%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference